ArticleJournal of diabetes investigation2026
Fasting proinsulin as a predictor of future glucose tolerance deterioration in Japanese adults.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
AIMS/
introductionProinsulin is associated with β-cell stress and has been linked to subsequent deterioration in glucose metabolism in Western populations, but its predictive value in Asian populations remains unclear. We investigated whether proinsulin is associated with future glucose tolerance deterioration in community-dwelling Japanese adults. MATERIALS AND
methodsOf 160 individuals who underwent a 75-g oral glucose tolerance test (OGTT) in 2020-2021, 88 completed a follow-up OGTT in 2024-2025. Fasting proinsulin concentrations were measured using stored baseline serum samples from 84 participants. Associations with glucose tolerance deterioration were examined using Firth's penalized logistic regression, and discriminatory performance was evaluated using receiver operating characteristic (ROC) analysis.
resultsDuring the 4-year follow-up, glucose tolerance deteriorated in 16 participants. Fasting proinsulin concentrations were higher in progressors than in non-progressors (5.8 vs. 3.6 pmol/L; P = 0.009). Each 1-standard deviation increase in fasting proinsulin was associated with glucose tolerance deterioration (odds ratio 2.11, 95% confidence interval 1.31-3.72; P = 0.002). In exploratory ROC analysis, the area under the curve was 0.710, and a cutoff of 5.1 pmol/L yielded 68.8% sensitivity and 83.8% specificity. Participants with elevated fasting proinsulin (≥ 5.1 pmol/L) and a low disposition index (≤ 1.27) had the highest odds of deterioration.
conclusionsFasting proinsulin may help identify Japanese adults at risk of future glucose tolerance deterioration, particularly when combined with indices of β-cell compensation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.